Baird Global Investment Banking Adds Ro Bhandari and Ben Port
New York, July 31, 2023 – Baird, an employee-owned, international financial services firm, announced today that Ro Bhandari has joined its Global Healthcare Investment Banking team as Managing Director covering Medical Technology. Bhandari will be joining the practice alongside Benjamin Port, who is set to join Baird in October, also as Managing Director on the Global Healthcare Investment Banking team covering Provider Services. Both Bhandari and Port will be based out of Baird’s New York office.
Bhandari joins Baird from William Blair where he was Partner and a Managing Director and Co-Head of MedTech Investment Banking. Before William Blair, Bhandari was a Vice President in the Healthcare Investment Banking Group of Morgan Stanley. Bhandari will partner with Rob Andrews and Ryan Mausehund to lead Baird’s Medical Technology coverage. Bhandari holds a bachelor’s degree from Dartmouth College and an MBA from Harvard Business School.
Port will join Baird from Moelis where he was Managing Director and Head of Healthcare Services M&A. Port will be rejoining Baird, where he worked prior to Moelis as Vice President. Port will partner with Jason Porter to lead Baird’s Provider Services coverage. Port holds both a bachelor’s degree and an MBA from the University of Virginia.
“We are excited to welcome Ro and Ben to the global Healthcare franchise as we continue to grow our platform and team,” said Bill Suddath, Co-Head of Baird Global Healthcare Investment Banking. “Baird has more than tripled the global Healthcare team in the last four years and equally has deepened our coverage and expertise across our strategic healthcare sub-verticals. Ro and Ben bring a wealth of experience, knowledge and relationships that will complement our team.”
“We are delighted that Ro and Ben have joined our fast-growing team,” said Rob Andrews, Co-Head of Baird Global Healthcare Investment Banking. “Leveraging their deep healthcare sector knowledge will help us to strengthen our overall healthcare offering to our global clients. We remain committed to advancing and investing in our global Healthcare platform.”
Baird’s Global Healthcare platform includes over 50 investment bankers, who have completed over 240 healthcare M&A and financing transactions since 2017; 8 Equity Research Analysts covering nearly 120 healthcare stocks; and a dedicated Equity Sales & Trading team. Baird continues to host its annual Global Healthcare Conference. This past year, the conference featured more than 100 presenting companies, 700+ attendees and 1,100+ one-on-one meetings.
About Baird Global Investment Banking
Baird is a leading global investment bank serving the M&A, equity capital markets, capital advisory and restructuring needs of its clients throughout the United States, Europe and Asia. Since 2018, Baird has completed nearly 800 advisory transactions, representing $335 billion in transaction value, and more than 400 financings, raising $181 billion.
Putting clients first since 1919, Baird is an employee-owned, international wealth management, asset management, investment banking/capital markets, and private equity firm with offices in the United States, Europe and Asia. Baird has more than 5,000 associates serving the needs of individual, corporate, institutional and municipal clients and approximately $376 billion in client assets as of December 31, 2022. Committed to being a great workplace, Baird ranked No. 23 on the 2023 Fortune 100 Best Companies to Work For® list – its 20th consecutive year on the list. Baird is the marketing name of Baird Financial Group. Baird’s principal operating subsidiaries are Robert W. Baird & Co. Incorporated and Baird Trust Company in the United States and Robert W. Baird Group Ltd. in Europe. Baird also has an operating subsidiary in Asia supporting Baird’s investment banking and private equity operations. For more information, please visit Baird’s website at www.rwbaird.com.
For additional information:
Baird Public Relations